Literature DB >> 29728705

Pathogenic variants in E3 ubiquitin ligase RLIM/RNF12 lead to a syndromic X-linked intellectual disability and behavior disorder.

Suzanna G M Frints1,2, Aysegul Ozanturk3, Germán Rodríguez Criado4, Ute Grasshoff5, Bas de Hoon6,7, Michael Field8, Sylvie Manouvrier-Hanu9,10, Scott E Hickey11,12, Molka Kammoun13, Karen W Gripp14, Claudia Bauer5, Christopher Schroeder5, Annick Toutain15,16, Theresa Mihalic Mosher11,12,17, Benjamin J Kelly17, Peter White12,17, Andreas Dufke5, Eveline Rentmeester6, Sungjin Moon3, Daniel C Koboldt12,17, Kees E P van Roozendaal18,19, Hao Hu20, Stefan A Haas21, Hans-Hilger Ropers20, Lucinda Murray8, Eric Haan22,23, Marie Shaw22, Renee Carroll22, Kathryn Friend24, Jan Liebelt23, Lynne Hobson24, Marjan De Rademaeker25, Joep Geraedts18,19, Jean-Pierre Fryns13, Joris Vermeesch13, Martine Raynaud15,16, Olaf Riess5, Joost Gribnau6, Nicholas Katsanis3, Koen Devriendt13, Peter Bauer5, Jozef Gecz22,26, Christelle Golzio3,27, Cristina Gontan6, Vera M Kalscheuer28.   

Abstract

RLIM, also known as RNF12, is an X-linked E3 ubiquitin ligase acting as a negative regulator of LIM-domain containing transcription factors and participates in X-chromosome inactivation (XCI) in mice. We report the genetic and clinical findings of 84 individuals from nine unrelated families, eight of whom who have pathogenic variants in RLIM (RING finger LIM domain-interacting protein). A total of 40 affected males have X-linked intellectual disability (XLID) and variable behavioral anomalies with or without congenital malformations. In contrast, 44 heterozygous female carriers have normal cognition and behavior, but eight showed mild physical features. All RLIM variants identified are missense changes co-segregating with the phenotype and predicted to affect protein function. Eight of the nine altered amino acids are conserved and lie either within a domain essential for binding interacting proteins or in the C-terminal RING finger catalytic domain. In vitro experiments revealed that these amino acid changes in the RLIM RING finger impaired RLIM ubiquitin ligase activity. In vivo experiments in rlim mutant zebrafish showed that wild type RLIM rescued the zebrafish rlim phenotype, whereas the patient-specific missense RLIM variants failed to rescue the phenotype and thus represent likely severe loss-of-function mutations. In summary, we identified a spectrum of RLIM missense variants causing syndromic XLID and affecting the ubiquitin ligase activity of RLIM, suggesting that enzymatic activity of RLIM is required for normal development, cognition and behavior.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29728705     DOI: 10.1038/s41380-018-0065-x

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  9 in total

1.  RLIM Is a Candidate Dosage-Sensitive Gene for Individuals with Varying Duplications of Xq13, Intellectual Disability, and Distinct Facial Features.

Authors:  Elizabeth E Palmer; Renee Carroll; Marie Shaw; Raman Kumar; Andre E Minoche; Melanie Leffler; Lucinda Murray; Rebecca Macintosh; Dale Wright; Chris Troedson; Fiona McKenzie; Sharron Townshend; Michelle Ward; Urwah Nawaz; Anja Ravine; Cassandra K Runke; Erik C Thorland; Marybeth Hummel; Nicola Foulds; Olivier Pichon; Bertrand Isidor; Cédric Le Caignec; Bénédicte Demeer; Joris Andrieux; Salam Hadah Albarazi; Ann Bye; Rani Sachdev; Edwin P Kirk; Mark J Cowley; Mike Field; Jozef Gecz
Journal:  Am J Hum Genet       Date:  2020-11-06       Impact factor: 11.025

2.  RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription.

Authors:  Fang Wang; Kailiang Zhao; Sixiang Yu; An Xu; Wei Han; Yide Mei
Journal:  J Biol Chem       Date:  2018-11-09       Impact factor: 5.157

3.  Activity-based probe profiling of RNF12 E3 ubiquitin ligase function in Tonne-Kalscheuer syndrome.

Authors:  Francisco Bustos; Sunil Mathur; Carmen Espejo-Serrano; Rachel Toth; C James Hastie; Satpal Virdee; Greg M Findlay
Journal:  Life Sci Alliance       Date:  2022-06-28

Review 4.  Ubiquitin ligases: guardians of mammalian development.

Authors:  David A Cruz Walma; Zhuoyao Chen; Alex N Bullock; Kenneth M Yamada
Journal:  Nat Rev Mol Cell Biol       Date:  2022-01-25       Impact factor: 113.915

5.  An RNF12-USP26 amplification loop drives germ cell specification and is disrupted by disease-associated mutations.

Authors:  Anna Segarra-Fas; Carmen Espejo-Serrano; Francisco Bustos; Houjiang Zhou; Feng Wang; Rachel Toth; Thomas Macartney; Ingolf Bach; Gino Nardocci; Greg M Findlay
Journal:  Sci Signal       Date:  2022-07-12       Impact factor: 9.517

6.  A novel RLIM/RNF12 variant disrupts protein stability and function to cause severe Tonne-Kalscheuer syndrome.

Authors:  Francisco Bustos; Carmen Espejo-Serrano; Anna Segarra-Fas; Rachel Toth; Alison J Eaton; Kristin D Kernohan; Meredith J Wilson; Lisa G Riley; Greg M Findlay
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.996

7.  Whole genome sequencing identifies a duplicated region encompassing Xq13.2q13.3 in a large Iranian family with intellectual disability.

Authors:  Sepideh Mehvari; Farzaneh Larti; Hao Hu; Zohreh Fattahi; Maryam Beheshtian; Seyedeh Sedigheh Abedini; Sanaz Arzhangi; Hans-Hilger Ropers; Vera M Kalscheuer; Daniel Auld; Kimia Kahrizi; Yasser Riazalhosseini; Hossein Najmabadi
Journal:  Mol Genet Genomic Med       Date:  2020-07-26       Impact factor: 2.183

8.  Functional Diversification of SRSF Protein Kinase to Control Ubiquitin-Dependent Neurodevelopmental Signaling.

Authors:  Francisco Bustos; Anna Segarra-Fas; Gino Nardocci; Andrew Cassidy; Odetta Antico; Lindsay Davidson; Lennart Brandenburg; Thomas J Macartney; Rachel Toth; C James Hastie; Jennifer Moran; Robert Gourlay; Joby Varghese; Renata F Soares; Martin Montecino; Greg M Findlay
Journal:  Dev Cell       Date:  2020-10-19       Impact factor: 12.270

9.  Sequential stabilization of RNF220 by RLIM and ZC4H2 during cerebellum development and Shh-group medulloblastoma progression.

Authors:  Yuwei Li; Chencheng Yang; Huishan Wang; Ling Zhao; Qinghua Kong; Yu Cang; Shuhua Zhao; Longbao Lv; Yan Li; Bingyu Mao; Pengcheng Ma
Journal:  J Mol Cell Biol       Date:  2022-04-05       Impact factor: 8.185

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.